OBJECTIVE: To assess the sizes of intra-abdominal organs of adult subjects with untreated severe congenital isolated GH deficiency (IGHD) due to lack of functional GHRH receptor (GHRH-R), and to verify whether there is proportionality between size of organ and adult stature and body surface area (BSA). SUBJECTS AND METHODS: By using ultrasound, we studied the sizes (absolute and corrected by height, weight and BSA) of the intra-abdominal organs of 18 adult subjects with IGHD (eight females, IGHD group) who have never received GH replacement therapy. They were all homozygous for the same null mutation (IVS1 + 1G --> A) in the GHRH receptor gene (GHRH-R). They were compared with normal controls from the same region. RESULTS: After correction for BSA, subjects lacking a functional GHRH-R have normal prostate and ovaries size, small spleen and uterus, and large liver, pancreas and kidney. CONCLUSIONS: Size of individual abdominal organs is influenced in different ways by severe and congenital lack of GH due to a GHRH-R mutation.
OBJECTIVE: To assess the sizes of intra-abdominal organs of adult subjects with untreated severe congenital isolated GH deficiency (IGHD) due to lack of functional GHRH receptor (GHRH-R), and to verify whether there is proportionality between size of organ and adult stature and body surface area (BSA). SUBJECTS AND METHODS: By using ultrasound, we studied the sizes (absolute and corrected by height, weight and BSA) of the intra-abdominal organs of 18 adult subjects with IGHD (eight females, IGHD group) who have never received GH replacement therapy. They were all homozygous for the same null mutation (IVS1 + 1G --> A) in the GHRH receptor gene (GHRH-R). They were compared with normal controls from the same region. RESULTS: After correction for BSA, subjects lacking a functional GHRH-R have normal prostate and ovaries size, small spleen and uterus, and large liver, pancreas and kidney. CONCLUSIONS: Size of individual abdominal organs is influenced in different ways by severe and congenital lack of GH due to a GHRH-R mutation.
Authors: K Sjögren; M Bohlooly-Y; Y M Bohlooly; B Olsson; K Coschigano; J Törnell; S Mohan; O G Isaksson; G Baumann; J Kopchick; C Ohlsson Journal: Biochem Biophys Res Commun Date: 2000-01-19 Impact factor: 3.575
Authors: Marta Regina Silva Alcântara; Roberto Salvatori; Paula Regina Silva Alcântara; Luciana Michele A Nóbrega; Vera Simone Campos; Elma Cristina O Oliveira; Marcelo Henrique S Oliveira; Anita Hermínia Oliveira Souza; Manuel Hermínio Aguiar-Oliveira Journal: J Clin Endocrinol Metab Date: 2006-01-04 Impact factor: 5.958
Authors: M Götzberger; C Weber; H C Kaiser; I Suttmann; M Calderon-Geisselreiter; U Müller-Lisse; W Heldwein; U Schiemann Journal: Praxis (Bern 1994) Date: 2006-01-25
Authors: Jean-Nicolas Vauthey; Eddie K Abdalla; Dorota A Doherty; Philippe Gertsch; Marc J Fenstermacher; Evelyne M Loyer; Jan Lerut; Roland Materne; Xuemei Wang; Arthur Encarnacion; Delise Herron; Christian Mathey; Giovanni Ferrari; Chuslip Charnsangavej; Kim-Anh Do; Alban Denys Journal: Liver Transpl Date: 2002-03 Impact factor: 5.799
Authors: José Augusto Soares Barreto-Filho; Marta Regina S Alcântara; Roberto Salvatori; Martha Azevedo Barreto; Antônio Carlos Sobral Sousa; Valquíria Bastos; Anita Hermínia Souza; Rossana Maria C Pereira; Peter E Clayton; Matthew S Gill; Manuel Hermínio Aguiar-Oliveira Journal: J Clin Endocrinol Metab Date: 2002-05 Impact factor: 5.958
Authors: M H Aguiar-Oliveira; M S Gill; E S de A Barretto; M R Alcântara; F Miraki-Moud; C A Menezes; A H Souza; C E Martinelli; F A Pereira; R Salvatori; M A Levine; S M Shalet; C Camacho-Hubner; P E Clayton Journal: J Clin Endocrinol Metab Date: 1999-11 Impact factor: 5.958
Authors: X D Peng ; S Park; M R Gadelha; K T Coschigano; J J Kopchick; L A Frohman; R D Kineman Journal: Endocrinology Date: 2001-03 Impact factor: 4.736
Authors: Menilson Menezes; Roberto Salvatori; Carla R P Oliveira; Rossana M C Pereira; Anita H O Souza; Luciana M A Nobrega; Edla A C Cruz; Marcos Menezes; Erica O Alves; Manuel H Aguiar-Oliveira Journal: Menopause Date: 2008 Jul-Aug Impact factor: 2.953
Authors: Manuel H Aguiar-Oliveira; Francielle T Oliveira; Rossana M C Pereira; Carla R P Oliveira; Amanda Blackford; Eugenia H O Valenca; Elenilde G Santos; Miburge B Gois-Junior; Rafael A Meneguz-Moreno; Vanessa P Araujo; Luis A Oliveira-Neto; Roque P Almeida; Mário A Santos; Natalia T Farias; Debora C R Silveira; Gabriel W Cabral; Flavia R Calazans; Juliane D Seabra; Tiago F Lopes; Endrigo O Rodrigues; Livia A Porto; Igor P Oliveira; Enaldo V Melo; Marco Martari; Roberto Salvatori Journal: J Clin Endocrinol Metab Date: 2009-12-04 Impact factor: 5.958
Authors: Viviane C Campos; Mônica R Barrios; Roberto Salvatori; Roque Pacheco de Almeida; Enaldo V de Melo; Ana C S Nascimento; Amélia Ribeiro de Jesus; Manuel H Aguiar-Oliveira Journal: Endocrine Date: 2016-08-03 Impact factor: 3.633
Authors: Menilson Menezes; Roberto Salvatori; Luiza D Melo; Ívina E S Rocha; Carla R P Oliveira; Rossana M C Pereira; Anita H O Souza; Eugênia H O Valença; Enaldo V Melo; Viviane C Campos; Flavia O Costa; Manuel H Aguiar-Oliveira Journal: Endocrine Date: 2013-02-10 Impact factor: 3.633
Authors: Mônica R Barrios; Viviane C Campos; Nalu T A Peres; Laís L de Oliveira; Rodrigo A Cazzaniga; Márcio B Santos; Murilo B Aires; Ricardo L L Silva; Aline Barreto; Hiro Goto; Roque P Almeida; Roberto Salvatori; Manuel H Aguiar-Oliveira; Amélia M R Jesus Journal: Front Cell Infect Microbiol Date: 2019-08-30 Impact factor: 5.293